Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.     This activity is supported by independent educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation. Wednesday, April 25, 2018 6:00 PM - 8:00 PM Boston Convention and Exhibition Center Room 151AB Boston, MA Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required. Held in conjunction with AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018. Click here to download the slides from this symposium. Don't miss the live webcast, "Meeting the Challenge of Psoriatic Disease: Optimal Care and Cost Management Strategies for Managed Care Live Webcast". Click here to register and for full accreditation information.   Hot Topics Assessment of current and emerging therapies Alignment of managed care treatment algorithms with recent clinical data Application of care pathways as a cost management tool in psoriatic disease Evolving specialty pharmacy and disease management services to improve outcomes   Expert Faculty Presenters Robin Dore, MD Clinical Professor of Medicine David Geffen School of Medicine at UCLA Jeffrey D. Dunn, PharmD, MBA Vice President, Clinical Strategy and Programs and Industry Relations Magellan Rx Management Paul Yamauchi, MD, PhD Clinical Assistant Professor of Dermatology David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Institute Dermatology Institute & Skin Care Center Clinical Science Institute   Who Should Attend? This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2018 Managed Care and Specialty Pharmacy Annual Meeting.   Statement of Need/Program Overview Psoriasis is one of the most common autoimmune diseases to develop in genetically susceptible individuals with an estimated 7.5 million Americans afflicted by psoriasis; and psoriatic arthritis is considered to be one of the most disabling types of arthritis affecting as many as 2.3 million Americans. As novel agents become available, treatment decision making is becoming more complex and managed care professionals need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. The expert faculty panel will present the latest clinical data to recommend appropriate therapies, utilize care pathways, design appropriate medical and pharmacy benefits, and implement health care quality measures.   Educational Objectives At the conclusion of this activity, participants should be able to demonstrate improved ability to: Assess current and emerging therapies for the treatment of psoriasis and psoriatic arthritis and cite their clinical trial data. Examine alignment of managed care psoriatic disease treatment algorithms with recent clinical trial data. Describe care pathways and their application as a cost management tool in psoriatic disease. Employ specialty pharmacy and disease management services for psoriatic disease patients.   Agenda Date and Time Wednesday, April 25, 2018 6:00 PM - 8:00 PM Boston Convention and Exhibition Center Room 151AB Boston, MA 6:00 PM Pre-Activity Learning Assessment and Opening Comments/Overview 6:05 PM Psoriasis Clinical Update: Assessing the Latest Trial Data and Treatment Algorithms Paul Yamauchi, MD, PhD 6:30 PM Psoriatic Arthritis Clinical Update: Assessing the Latest Trial Data and Treatment Algorithms Robin Dore, MD 6:55 PM Care Pathways in Psoriatic Disease: Recommendations for Managed Care Jeffrey D. Dunn, PharmD, MBA 7:15 PM Improving Patient Outcomes with Specialty Pharmacy Services and Disease Management Strategies Jeffrey D. Dunn, PharmD, MBA 7:40 PM Audience Q&A Session 7:55 PM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation 8:00 PM Adjournment   Accreditation Information Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physician Continuing Medical Education The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008162-9999-18-046-L01-P Type of Activity: Application For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. Please note: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act ♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required. Pre-registration will close at 12:00 pm on April 24, 2018. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.